
AMI Labs CEO Rejects AGI Hype as Startup Bets on World Models for Robotics
AMI Labs CEO Alexandre LeBrun rejects AGI hype, betting on world models to power safer robotics and physical AI.
AI advancements in medical diagnostics, treatment, and patient care.

AMI Labs CEO Alexandre LeBrun rejects AGI hype, betting on world models to power safer robotics and physical AI.

Brain AI startup Hemispheric raised $52 million to build a model that reads EEG signals and could help diagnose PTSD, depression and more.

OpenAI researcher Miles Wang is reportedly launching an AI drug discovery startup, signaling soaring investor interest in biotech AI.

Anthropic is entering AI drug discovery with Claude Science and plans to pursue its own medicines, but the path to patients remains long.

Midjourney’s new medical scanner video shows more hardware, but little proof the ultrasound system can deliver on its bold health claims.

A founder with rare lymphoma used wearables, Claude and second opinions to navigate treatment and avoid unnecessary radiotherapy.

Fitbit Air blends simple tracking with an optional AI health coach, showing how Google is trying to make Fitbit more useful without forcing AI.

Midjourney’s medical imaging push is drawing skepticism as experts question the evidence, physics and wellness-first marketing behind the scanner.

Britain’s Largest AI Compute Initiative Goes Live In a bold stride toward technological sovereignty and scientific advancement, the United Kingdom officially launched Isambard‑AI, a £225…

DeepMind’s groundbreaking protein-prediction tool, AlphaFold3, has officially become more accessible to researchers worldwide. After months of anticipation, the London-based AI powerhouse has released the software…